It has also been demonstrated that FGFR3 expression follows the distribution of FGFR3 mutations, with significantly higher levels of expression in low stage and grade bladder tumors than in invasive carcinomas [65, 80, 82, 84]. The gene discussed is FGFR3; the disease is urinary bladder neoplasm.